Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Radiotherapy - what's new? Q & A

Future Horizons in Lung Cancer

Sorry, this item is currently unavailable.

Published: 5 Oct 2016

Views: 1700

Rating:

Save

Dr David Landau and Prof Corinne Favire-Finn

Dr Landau and Prof Favire-Finn answer questions on their sessions discussing advances in radiotherapy, at the Future Horizons in Lung Cancer meeting.

Related Videos

Changing landscape of breast cancer diagnosis

Dr Nisha Vishnu - Fortis Healthcare & MACs Clinic, Bangalore, India

Changing landscape of breast cancer diagnosis ( Dr Nisha Vishnu - Fortis Healthcare & MACs Clinic, Bangalore, India )

Biomarkers, predictive and prognostic factors of resistance to immunotherapy

Dr Ignacio Gil-Bazo - Fundación Instituto Valenciano de Oncología (FIVO)...

Biomarkers, predictive and prognostic factors of resistance to immunotherapy ( Dr Ignacio Gil-Bazo - Fundación Instituto Valenciano de Oncología (FIVO)/Clínica Universidad de Navarra, Spain )

Research highlights in lung cancer

Dr Meri Muminovic - Memorial Cancer Institute, Miami, USA

Research highlights in lung cancer ( Dr Meri Muminovic - Memorial Cancer Institute, Miami, USA )

Uncommon genetic aberrations NTRK, RET, NRG

Dr Luis E. Raez - Memorial Cancer Institute, Miami, USA

Uncommon genetic aberrations NTRK, RET, NRG ( Dr Luis E. Raez - Memorial Cancer Institute, Miami, USA )

ASCO 2024: Lung cancer highlights

Dr Antonio Passaro, Dr Matthew Krebs, Prof Raffaele Califano, Prof Nicolas...

ASCO 2024: Lung cancer highlights ( Dr Antonio Passaro, Dr Matthew Krebs, Prof Raffaele Califano, Prof Nicolas Girard and Dr Anna Minchom )

Maintenance systemic therapy versus local consolidative therapy plus...

Dr Puneeth Iyengar - Memorial Sloan Kettering Cancer Center, New York, USA

Maintenance systemic therapy versus local consolidative therapy plus maintenance systemic therapy for NSCLC ( Dr Puneeth Iyengar - Memorial Sloan Kettering Cancer Center, New York, USA )

Twice-daily chemoradiation remains the standard of care in limited stage small...

Dr Gerard Walls - Queen's University Belfast, Belfast, Northern Ireland

Twice-daily chemoradiation remains the standard of care in limited stage small-cell lung cancer ( Dr Gerard Walls - Queen's University Belfast, Belfast, Northern Ireland )

Feasibility and safety of boost at 74 Gy based on interim FDG-PET during...

Prof Gerard Zalcman - Université de Paris, Paris, France

Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients ( Prof Gerard Zalcman - Université de Paris, Paris, France )

The 5-year long-term outcomes of radiation technique for locally advanced NSCLC

Dr Stephen Chun - MD Anderson, Houston, USA

The 5-year long-term outcomes of radiation technique for locally advanced NSCLC ( Dr Stephen Chun - MD Anderson, Houston, USA )

More from ecancer